Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

A pilot evaluation of a computer-based psychometric test battery designed to detect impairment in patients with cirrhosis.

Cook NA, Kim JU, Pasha Y, Crossey MM, Schembri AJ, Harel BT, Kimhofer T, Taylor-Robinson SD.

Int J Gen Med. 2017 Sep 6;10:281-289. doi: 10.2147/IJGM.S140197. eCollection 2017.

2.

Improving American Healthcare Through "Clinical Lab 2.0": A Project Santa Fe Report.

Crawford JM, Shotorbani K, Sharma G, Crossey M, Kothari T, Lorey TS, Prichard JW, Wilkerson M, Fisher N.

Acad Pathol. 2017 Apr 18;4:2374289517701067. doi: 10.1177/2374289517701067. eCollection 2017 Jan-Dec.

3.

The Plasma and Serum Metabotyping of Hepatocellular Carcinoma in a Nigerian and Egyptian Cohort using Proton Nuclear Magnetic Resonance Spectroscopy.

Shariff MIF, Kim JU, Ladep NG, Gomaa AI, Crossey MME, Okeke E, Banwat E, Waked I, Cox IJ, Williams R, Holmes E, Taylor-Robinson SD.

J Clin Exp Hepatol. 2017 Jun;7(2):83-92. doi: 10.1016/j.jceh.2017.03.007. Epub 2017 Mar 15.

4.

From decentralization to commonization of HIV healthcare resources: keys to reduction in health disparity and equitable distribution of health services in Nigeria.

Oleribe OO, Oladipo OA, Ezieme IP, Crossey MM, Taylor-Robinson SD.

Pan Afr Med J. 2016 Jul 21;24:266. doi: 10.11604/pamj.2016.24.266.6286. eCollection 2016.

5.

Hepatitis C in Egypt - past, present, and future.

Elgharably A, Gomaa AI, Crossey MM, Norsworthy PJ, Waked I, Taylor-Robinson SD.

Int J Gen Med. 2016 Dec 20;10:1-6. doi: 10.2147/IJGM.S119301. eCollection 2017. Review.

6.

Hepatic steatosis and fibrosis: Non-invasive assessment.

Karanjia RN, Crossey MM, Cox IJ, Fye HK, Njie R, Goldin RD, Taylor-Robinson SD.

World J Gastroenterol. 2016 Dec 7;22(45):9880-9897. doi: 10.3748/wjg.v22.i45.9880. Review.

7.

Urinary Metabotyping of Hepatocellular Carcinoma in a UK Cohort Using Proton Nuclear Magnetic Resonance Spectroscopy.

Shariff MI, Kim JU, Ladep NG, Crossey MM, Koomson LK, Zabron A, Reeves H, Cramp M, Ryder S, Greer S, Cox IJ, Williams R, Holmes E, Nash K, Taylor-Robinson SD.

J Clin Exp Hepatol. 2016 Sep;6(3):186-194. Epub 2016 Apr 20.

8.

Urinary metabolic profiling by 1H NMR spectroscopy in patients with cirrhosis may discriminate overt but not covert hepatic encephalopathy.

McPhail MJ, Montagnese S, Villanova M, El Hadi H, Amodio P, Crossey MM, Williams R, Cox IJ, Taylor-Robinson SD.

Metab Brain Dis. 2017 Apr;32(2):331-341. doi: 10.1007/s11011-016-9904-0. Epub 2016 Sep 17.

9.

Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging.

Grover VP, Southern L, Dyson JK, Kim JU, Crossey MM, Wylezinska-Arridge M, Patel N, Fitzpatrick JA, Bak-Bol A, Waldman AD, Alexander GJ, Mells GF, Chapman RW, Jones DE, Taylor-Robinson SD.

Aliment Pharmacol Ther. 2016 Nov;44(9):936-945. doi: 10.1111/apt.13797. Epub 2016 Sep 8.

10.

A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy.

Grover VP, McPhail MJ, Wylezinska-Arridge M, Crossey MM, Fitzpatrick JA, Southern L, Saxby BK, Cook NA, Cox IJ, Waldman AD, Dhanjal NS, Bak-Bol A, Williams R, Morgan MY, Taylor-Robinson SD.

Metab Brain Dis. 2017 Feb;32(1):77-86. doi: 10.1007/s11011-016-9881-3. Epub 2016 Aug 3.

11.

Changes in Liver Volume in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy.

Fitzpatrick JA, Kim JU, Cobbold JF, McPhail MJ, Crossey MM, Bak-Bol AA, Zaky A, Taylor-Robinson SD.

J Clin Exp Hepatol. 2016 Mar;6(1):15-20. doi: 10.1016/j.jceh.2015.11.004. Epub 2015 Dec 6.

12.

Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study.

Cox IJ, Aliev AE, Crossey MM, Dawood M, Al-Mahtab M, Akbar SM, Rahman S, Riva A, Williams R, Taylor-Robinson SD.

World J Gastroenterol. 2016 Apr 28;22(16):4191-200. doi: 10.3748/wjg.v22.i16.4191.

13.

Hepatocellular carcinoma: Review of disease and tumor biomarkers.

Kim JU, Shariff MI, Crossey MM, Gomez-Romero M, Holmes E, Cox IJ, Fye HK, Njie R, Taylor-Robinson SD.

World J Hepatol. 2016 Apr 8;8(10):471-84. doi: 10.4254/wjh.v8.i10.471. Review.

14.

Magnetic Resonance Spectroscopy: Principles and Techniques: Lessons for Clinicians.

Tognarelli JM, Dawood M, Shariff MI, Grover VP, Crossey MM, Cox IJ, Taylor-Robinson SD, McPhail MJ.

J Clin Exp Hepatol. 2015 Dec;5(4):320-8. doi: 10.1016/j.jceh.2015.10.006. Epub 2015 Nov 12. Review.

15.

Plasma Lipid Profiling in a Rat Model of Hepatocellular Carcinoma: Potential Modulation Through Quinolone Administration.

Shariff MI, Tognarelli JM, Lewis MR, Want EJ, Mohamed Fel Z, Ladep NG, Crossey MM, Khan SA, Jalan R, Holmes E, Taylor-Robinson SD.

J Clin Exp Hepatol. 2015 Dec;5(4):286-94. doi: 10.1016/j.jceh.2015.07.205. Epub 2015 Jul 18.

16.

Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis.

McPhail MJW, Shawcross DL, Lewis MR, Coltart I, Want EJ, Antoniades CG, Veselkov K, Triantafyllou E, Patel V, Pop O, Gomez-Romero M, Kyriakides M, Zia R, Abeles RD, Crossey MME, Jassem W, O'Grady J, Heaton N, Auzinger G, Bernal W, Quaglia A, Coen M, Nicholson JK, Wendon JA, Holmes E, Taylor-Robinson SD.

J Hepatol. 2016 May;64(5):1058-1067. doi: 10.1016/j.jhep.2016.01.003. Epub 2016 Jan 18.

17.

Reasons why West Africa continues to be a hotbed for hepatocellular carcinoma.

Tognarelli J, Ladep NG, Crossey MM, Okeke E, Duguru M, Banwat E, Taylor-Robinson SD.

Niger Med J. 2015 Jul-Aug;56(4):231-5. doi: 10.4103/0300-1652.165032. Review.

18.

Ebola: is the response justified?

Lewis H, Chaudry A, Ndow G, Crossey MM, Garside D, Njie R, Taylor-Robinson SD.

Pan Afr Med J. 2015 Oct 11;22 Suppl 1:23. doi: 10.11694/pamj.supp.2015.22.1.6598. eCollection 2015. Review.

19.

Nigerian response to the 2014 Ebola viral disease outbreak: lessons and cautions.

Oleribe OO, Crossey MM, Taylor-Robinson SD.

Pan Afr Med J. 2015 Oct 10;22 Suppl 1:13. doi: 10.11694/pamj.supp.2015.22.1.6490. eCollection 2015.

20.

The why and wherefore of hepatic encephalopathy.

Grover VP, Tognarelli JM, Massie N, Crossey MM, Cook NA, Taylor-Robinson SD.

Int J Gen Med. 2015 Dec 16;8:381-90. doi: 10.2147/IJGM.S86854. eCollection 2015. Review.

21.

Magnetic Resonance Imaging: Principles and Techniques: Lessons for Clinicians.

Grover VP, Tognarelli JM, Crossey MM, Cox IJ, Taylor-Robinson SD, McPhail MJ.

J Clin Exp Hepatol. 2015 Sep;5(3):246-55. doi: 10.1016/j.jceh.2015.08.001. Epub 2015 Aug 20. Review.

22.

Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers.

Trovato FM, Tognarelli JM, Crossey MM, Catalano D, Taylor-Robinson SD, Trovato GM.

World J Hepatol. 2015 Nov 18;7(26):2664-75. doi: 10.4254/wjh.v7.i26.2664. Review.

23.

Diagnosing and treating hepatic encephalopathy.

Tiberi O, Tognarelli JM, Cook NA, Crossey MM, Dhanjal NS, Taylor-Robinson SD.

Br J Hosp Med (Lond). 2015 Nov;76(11):646, 648-52, 654. doi: 10.12968/hmed.2015.76.11.646. Review.

PMID:
26551495
24.

Apolipoprotein E-ε4 deficiency and cognitive function in hepatitis C virus-infected patients.

Wozniak MA, Lugo Iparraguirre LM, Dirks M, Deb-Chatterji M, Pflugrad H, Goldbecker A, Tryc AB, Worthmann H, Gess M, Crossey MM, Forton DM, Taylor-Robinson SD, Itzhaki RF, Weissenborn K.

J Viral Hepat. 2016 Jan;23(1):39-46. doi: 10.1111/jvh.12443. Epub 2015 Aug 26.

25.

Prevention of Liver Fibrosis and Cancer in Africa: The PROLIFICA project--a collaborative study of hepatitis B-related liver disease in West Africa.

Howell J, Ladep NG, Lemoine M, Nayagam S, Toure PS, Diop MM, Daveiga Joao Armindo, Sall AS, Lo G, Crossey MM, Thursz MR, Taylor-Robinson SD, Ka MM.

S Afr Med J. 2015 Mar;105(3):185-6. No abstract available.

26.

Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study.

Grover VP, Crossey MM, Fitzpatrick JA, Saxby BK, Shaw R, Waldman AD, Morgan MY, Taylor-Robinson SD.

Metab Brain Dis. 2016 Dec;31(6):1315-1325. Epub 2015 Aug 8.

27.

Liver and spleen transient elastography and Acoustic Radiation Force Impulse Measurements. Performance and comparison of measurements in the same area concurrently assessed for liver fibrosis by biopsy.

Trovato FM, Atzori S, Musumeci G, Tooley V, Marcinkowski H, Crossey MM, Ladep NG, Martines GF, Goldin RD, Taylor-Robinson SD.

Adv Med Sci. 2015 Sep;60(2):300-6. doi: 10.1016/j.advms.2015.06.001. Epub 2015 Jun 13.

PMID:
26143473
28.

PROLIFICA: a story of West African clinical and research collaborations to target hepatitis B-related hepatocellular carcinoma in West Africa.

Howell J, Ladep NG, Nayagam S, Lemoine M, Garside DA, Crossey MME, Okeke E, Njie R, Ka MM, Taal M, Thursz MR, Taylor-Robinson SD.

QJM. 2016 Jun;109(6):373-375. doi: 10.1093/qjmed/hcv118. Epub 2015 Jun 22. No abstract available.

29.

Research collaborations in Tajikistan: lessons to be learnt.

Massie N, Crossey MM, Garside DA, Taylor-Robinson SD.

QJM. 2015 Oct;108(10):761-3. doi: 10.1093/qjmed/hcv050. Epub 2015 Feb 23. Review.

PMID:
25713422
30.

Evidence is weak to support hepatocellular carcinoma screening in chronic liver disease.

Taylor-Robinson SD, Wong J, Crossey MM, Khan SA.

Evid Based Med. 2015 Apr;20(2):59. doi: 10.1136/ebmed-2014-110107. Epub 2015 Feb 18. No abstract available.

PMID:
25694341
31.

Sustainable Health Development Goals (SHDG): breaking down the walls.

Oleribe OO, Crossey MM, Taylor-Robinson SD.

Pan Afr Med J. 2015 Nov 26;22:306. doi: 10.11604/pamj.2015.22.306.6468. eCollection 2015.

32.

PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolism.

Bridge SH, Sheridan DA, Felmlee DJ, Crossey MM, Fenwick FI, Lanyon CV, Dubuc G, Seidah NG, Davignon J, Thomas HC, Taylor-Robinson SD, Toms GL, Neely RD, Bassendine MF.

J Hepatol. 2015 Apr;62(4):763-70. doi: 10.1016/j.jhep.2014.11.016. Epub 2014 Nov 21.

PMID:
25463543
33.

Problem of hepatocellular carcinoma in West Africa.

Ladep NG, Lesi OA, Mark P, Lemoine M, Onyekwere C, Afihene M, Crossey MM, Taylor-Robinson SD.

World J Hepatol. 2014 Nov 27;6(11):783-92. doi: 10.4254/wjh.v6.i11.783. Review.

34.

Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.

Bajaj JS, Cox IJ, Betrapally NS, Heuman DM, Schubert ML, Ratneswaran M, Hylemon PB, White MB, Daita K, Noble NA, Sikaroodi M, Williams R, Crossey MM, Taylor-Robinson SD, Gillevet PM.

Am J Physiol Gastrointest Liver Physiol. 2014 Nov 15;307(10):G951-7. doi: 10.1152/ajpgi.00268.2014. Epub 2014 Sep 25.

35.

Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans.

Ladep NG, Dona AC, Lewis MR, Crossey MM, Lemoine M, Okeke E, Shimakawa Y, Duguru M, Njai HF, Fye HK, Taal M, Chetwood J, Kasstan B, Khan SA, Garside DA, Wijeyesekera A, Thillainayagam AV, Banwat E, Thursz MR, Nicholson JK, Njie R, Holmes E, Taylor-Robinson SD.

Hepatology. 2014 Oct;60(4):1291-301. doi: 10.1002/hep.27264. Epub 2014 Aug 25.

PMID:
24923488
36.

An ALTernate interpretation of serum transaminases.

Alcorn J, Crossey MJ.

Dig Dis Sci. 2014 Jun;59(6):1085-7. doi: 10.1007/s10620-014-3123-5. Epub 2014 Apr 12. No abstract available.

PMID:
24728966
37.

Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency.

Sheridan DA, Bridge SH, Crossey MM, Felmlee DJ, Thomas HC, Neely RD, Taylor-Robinson SD, Bassendine MF.

Metab Brain Dis. 2014 Sep;29(3):625-34. doi: 10.1007/s11011-014-9520-9. Epub 2014 Mar 12.

PMID:
24615429
38.

Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.

Ladep NG, Khan SA, Crossey MM, Thillainayagam AV, Taylor-Robinson SD, Toledano MB.

World J Gastroenterol. 2014 Feb 14;20(6):1544-53. doi: 10.3748/wjg.v20.i6.1544.

39.

Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial.

Sheridan DA, Bridge SH, Crossey MM, Felmlee DJ, Fenwick FI, Thomas HC, Neely RD, Taylor-Robinson SD, Bassendine MF.

Liver Int. 2014 May;34(5):737-47. doi: 10.1111/liv.12316. Epub 2013 Oct 14.

PMID:
24118830
40.

Modulation of neural activation following treatment of hepatic encephalopathy.

McPhail MJ, Leech R, Grover VP, Fitzpatrick JA, Dhanjal NS, Crossey MM, Pflugrad H, Saxby BK, Wesnes K, Dresner MA, Waldman AD, Thomas HC, Taylor-Robinson SD.

Neurology. 2013 Mar 12;80(11):1041-7. doi: 10.1212/WNL.0b013e31828726e1. Epub 2013 Feb 20.

41.

A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy.

Bajaj JS, Gillevet PM, Patel NR, Ahluwalia V, Ridlon JM, Kettenmann B, Schubert CM, Sikaroodi M, Heuman DM, Crossey MM, Bell DE, Hylemon PB, Fatouros PP, Taylor-Robinson SD.

Metab Brain Dis. 2012 Jun;27(2):205-15. doi: 10.1007/s11011-012-9303-0. Epub 2012 Apr 12.

PMID:
22527995
42.

Accuracy and reliability of microbubble ultrasound measurements for the non-invasive assessment of hepatic fibrosis in chronic hepatitis C.

Cobbold JF, Patel D, Fitzpatrick JA, Patel N, Crossey MM, Abdalla MS, Goldin RD, Vennart W, Thomas HC, Taylor-Robinson SD.

Hepatol Res. 2012 May;42(5):515-22. doi: 10.1111/j.1872-034X.2011.00948.x.

PMID:
22502745
43.

Neuropsychological tools in hepatology: a survival guide for the clinician.

Montagnese S, Schiff S, De Rui M, Crossey MM, Amodio P, Taylor-Robinson SD.

J Viral Hepat. 2012 May;19(5):307-15. doi: 10.1111/j.1365-2893.2012.01592.x. Review.

PMID:
22497809
44.

Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: evidence for an association with interferon sensitivity.

Sheridan DA, Bridge SH, Felmlee DJ, Crossey MM, Thomas HC, Taylor-Robinson SD, Toms GL, Neely RD, Bassendine MF.

J Hepatol. 2012 Jul;57(1):32-8. doi: 10.1016/j.jhep.2012.02.017. Epub 2012 Mar 10.

PMID:
22414761
45.

A toxicology-based review of fentanyl-related deaths in New Mexico (1986-2007).

Krinsky CS, Lathrop SL, Crossey M, Baker G, Zumwalt R.

Am J Forensic Med Pathol. 2011 Dec;32(4):347-51. doi: 10.1097/PAF.0b013e31822ad269.

PMID:
21986276
46.

A comparison of 31P magnetic resonance spectroscopy and microbubble-enhanced ultrasound for characterizing hepatitis c-related liver disease.

Lim AK, Patel N, Eckersley RJ, Fitzpatrick J, Crossey MM, Hamilton G, Goldin RD, Thomas HC, Vennart W, Cosgrove DO, Taylor-Robinson SD.

J Viral Hepat. 2011 Oct;18(10):e530-4. doi: 10.1111/j.1365-2893.2011.01455.x. Epub 2011 Apr 4.

PMID:
21914073
47.

Assessment of the vitamin B12 status of pregnant women in Nigeria using plasma holotranscobalamin.

Vanderjagt DJ, Ujah IA, Ikeh EI, Bryant J, Pam V, Hilgart A, Crossey MJ, Glew RH.

ISRN Obstet Gynecol. 2011;2011:365894. doi: 10.5402/2011/365894. Epub 2011 Jul 14.

48.

Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma.

Hashim Abdalla MS, Taylor-Robinson SD, Sharif AW, Williams HR, Crossey MM, Badra GA, Thillainayagam AV, Bansi DS, Thomas HC, Waked IA, Khan SA.

HPB (Oxford). 2011 Jun;13(6):385-90. doi: 10.1111/j.1477-2574.2011.00296.x. Epub 2011 Mar 22.

49.

Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study.

Shariff MI, Gomaa AI, Cox IJ, Patel M, Williams HR, Crossey MM, Thillainayagam AV, Thomas HC, Waked I, Khan SA, Taylor-Robinson SD.

J Proteome Res. 2011 Apr 1;10(4):1828-36. doi: 10.1021/pr101096f. Epub 2011 Mar 9.

PMID:
21275434
50.

A comparison of single-voxel clinical in vivo hepatic 31P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased states.

Wylezinska M, Cobbold JF, Fitzpatrick J, McPhail MJ, Crossey MM, Thomas HC, Hajnal JV, Vennart W, Cox IJ, Taylor-Robinson SD.

NMR Biomed. 2011 Apr;24(3):231-7. doi: 10.1002/nbm.1578. Epub 2010 Oct 15.

PMID:
20949641

Supplemental Content

Loading ...
Support Center